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Corneal transplantation, or keratoplasty, is one of the most successful forms of transplantation performed using allogenic tissue. However, many countries suffer from a shortage of donor corneas, and corneal disease accounts for millions of blind patients worldwide. The development of a stable keratoprosthesis (KPros) may be a solution towards solving this problem. Several models of Kpros are already in clinical use [1] [2] [3] [4] [5] , and 2 models are currently approved by the FDA 2, 6 . The stability of Kpros was greatly enhanced by the design of a porous skirt that allowed the integration of host corneal tissue into prosthetic peripheral region 7 .
One candidate material for a biocompatible artificial cornea is poly (vinyl alcohol) (PVA). Low temperature-crystallized PVA is transparent, and has mechanical properties suitable for Kpros 8 . Although pure PVA shows low cell affinity, we have
shown that covalent immobilization of collagen type I to the surface of PVA (PVA -COL) combined with air-lift organotypic culture techniques support a fully stratified corneal epithelium, which show similar physiological and morphological characteristics with the native cornea 9 . However, in vivo stability was not achieved due to the lack of basement membrane components required for a stable epithelium.
Attempts to improve in vivo stability include hybrid polymers that combine both artificial polymers and biological molecules to design corneal scaffolds that can support cell growth 10 . These polymers allow for regeneration of cornea nerves which are crucial in maintenance of an intact ocular surface following surgery. However, biodegradable materials alone are also unstable in the presence of inflammation, which may cause degradation of polymers by proteases 11 . In an attempt to take advantage of both the stability of artificial polymers with the biocompatibility of natural materials, we designed a hybrid polymer composed of a PVA hydrogel with amniotic membrane [12] [13] [14] , and has proven to be useful as a biological carrier for epithelial sheet transplants 15 . Here we show that a PVA based keratoprosthesis prototype with an AM surface (PVA -AM) allows for a fully stratified epithelium with intact basement membrane components that was not achieved with PVA -COL.
MATERIALS AND METHODS

Immobilization of amniotic membrane onto collagen-PVA
PVA -COL was prepared as described previously 16, 17 . Briefly, PVA powder The PVA hydrogel was dehydrated for further surface modification. Isocyanate groups were first introduced onto the surface by using hexamethylene dissocyantate (HMDI).
The activated PVA was immersed in type I collagen solution (porcine skin, 0.5 mg/ml, Nitta Gelatin Co Ltd, Osaka, Japan) to immobilize the collagen on the surface of the PVA. PVA -COL was then washed successively with phosphate buffered saline (PBS) using an ultrasonic cleaner for 10 min in order to remove the absorbed collagen, and sterilized by UV irradiation. Amount of collagen immobilized was determined by the bicinchoninic acid (BCA) protein assay by measuring the absorbance (562 nm) with a multi-plate reader, GENios, TECAN Japan Co. Ltd, Japan. From the result, it was
found that approximately 0.5 µg/cm 2 of collagen was covalently immobilized on the surface.
Human AM were obtained as previously described after written informed (Fig. 3F ) likewise normal rabbit corneal epithelium (Fig. 3G) .
Intracorneal implants
PVA -AM and PVA -COL were transplanted into the rabbit stroma, and animals were sacrificed after 5 weeks. All 3 eyes transplanted with PVA -COL lost epithelium by 2 weeks (Fig.4A) . On the other hand, of the 10 rabbits transplanted with PVA -AM, 5 eyes had partial epithelialization and 5 eyes had complete epithelialization at 2weeks (Fig.4B) . Fluorescein exclusion stains showed that the epithelium was intact, and that the fluorescent dye did not diffuse into the stroma. Typical HE staining of PVA -COL at 2 weeks shows a defect in the stratified epithelium (Fig. 4C) , while epithelialization on PVA -AM was intact (Fig. 4D ). Rabbits were followed for up to 5 weeks, at which point rabbits with inflammation deveolped epithelial defects due to disintegration of the AM.
DISCUSSION
We have shown in our previous report that surface modified PVA (PVA -COL) can support a fully stratified corneal epithelium that express appropriate differentiation markers, as well as form a functional barrier at the apical junction 9 . However, cross-linking with type I collagen was not sufficient to form a normal basement membrane complex to allow firm attachment of epithelial cells in vivo. This also led to incomplete differentiation of cells in different layers of the epithelium. In the present study, we crosslinked human AM to PVA in order to resolve the shortages observed in Y. Uchino et al. Amniotic membrane-PVA corneal scaffold the PVA -COL prototype. As expected, PVA -AM supported a stratified epithelial layer, with a more differentiated morphology observed in each layer of stratification (Fig. 1) .
While the epithelial cells on PVA -COL were irregular in size and shape, cells and has since proven to be useful in several aspects of reconstruction of the corneal structure 13 . Recent trends in regenerative medicine using tissue engineering techniques led to the clinical use of cultured epithelial sheet transplants using both carrier-free and AM carriers 15 . Our own clinical experience with cultivated AM sheets has produced clinical results comparable to a more conventional technique of corneal epithelial stem cell transplantation 21 . In this aspect, using AM as an artificial cornea components An AM epithelial sheet alone is too thin to serve as an artificial cornea. As shown in Fig.1 , the AM-epithelium complex is less than 10% of the entire corneal thickness, which is approximately 500 µm in humans. The PVA -AM hybrid polymer can compensate for the thinness of AM alone, while maintaining a transparent medium.
The presence of PVA beneath the epithelium does not hinder the transportation of glucose from the anterior chamber of the eye 9 . Furthermore, the additional thickness and material property of PVA will facilitate handling of the polymer during surgery. In our transplantation experiments, we found PVA -AM easy to maneuver and transplant to the cornea. Epithelium following surgery was intact for a longer period of time compared to the PVA -COL model reported previously. An intact epithelium that excludes fluorescein dye was observed for over 4 weeks following surgery. However, we found that some of the transplanted eyes developed epithelial defect towards the end of the observation period. Loss of AM was observed in eyes with epithelial defects.
We have also experienced the disintegration of AM in some clinical cases with inflammation (unpublished observation).
Stabilizing the AM component of PVA -AM is still an issue remaining to be 
